ROANOKE, Va., June 7, 2011 /PRNewswire/ — CMR Institute,
the leading provider of non-brand related education for
biopharmaceutical representatives and managers, announces the
addition of two new e-modules to help representatives better
prepare for changes created by the Affordable Care Act (ACA):
-
The Affordable Care Act and Its Implications for the
Pharmaceutical Industry -
Accountable Care Organizations and Future Healthcare
Delivery
These new modules help representatives understand how key
provisions of the ACA and elements of accountable care
organizations (ACOs) will ultimately impact providers, payers, and
patient care. As a result, reps will be more confident and better
prepared to deliver value when interacting with physicians and
other healthcare providers.
Key topics include:
- Overview of Accountable Care Organizations (ACOs) and their
role under the ACA - Understanding new quality mandates and reimbursement policies
for providers - The role of national research institutes in monitoring and
reporting patient outcomes - Changes in FDA approval for biologics
- Comparative effectiveness research (CER) and its impact on
evaluating treatment effectiveness
“In its current form, the Affordable Care Act will radically
change how provider groups are reimbursed, initially for Medicare
and Medicaid programs but eventually for other insured groups,”
says Cherie
Hicks, CPA, President and CEO of CMR Institute. “Our new
e-learning modules help repr
‘/>”/>
SOURCE